The largest database of trusted experimental protocols

12 ham dmem f12 medium

Manufactured by Merck Group
Sourced in United States

-12 Ham (DMEM/F12) medium is a proprietary cell culture medium formulation developed by Merck Group. It is designed to support the growth and maintenance of a variety of cell types in vitro. The medium provides essential nutrients, vitamins, and other components necessary for cell proliferation and survival.

Automatically generated - may contain errors

2 protocols using 12 ham dmem f12 medium

1

Neuroprotective Effects of Cannabinol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SH-SY5Y cell line was obtained from the American Type Culture Collection (ATCC) (Manassas, VA, USA). Cells were cultured using Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham (DMEM/F12) medium (Sigma-Aldrich, Saint Louis, MO, USA), containing 10% Fetal Bovine Serum (FBS) (Sigma-Aldrich, Saint Louis, MO, USA), 1% glutamine, and 1% penicillin-streptomycin. In order to induce neuronal differentiation, SH-SY5Y cells were treated with 10 µM RA for 5 days. At the end of the 5-day-differentiation, the medium was replaced with fresh medium with or without CBN at the concentration 10 or 20 µM (dissolved in DMSO; final DMSO concentration <0.1%). A previous report showed no cytotoxicity at these concentrations [12 (link)]. After 24 h of pre-treatment, the medium was changed with fresh medium with 1 mM MPP+ dissolved in water for 48 h. The MPP+ concentration and time of exposure were chosen on the basis of a previous report [15 (link)]. Control cells were incubated with DMEM/F12 medium supplemented with 10% FBS.
+ Open protocol
+ Expand
2

Characterization of Pathogenic and Recombinant Avian Adenoviruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chicken Leghorn male hepatocellular (LMH) cells were maintained in Dulbecco’s modified Eagle’s medium/nutrient mixture F-12 ham (DMEM/F12) medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO, USA) and incubated at 37 °C in 5% CO2.
The highly pathogenic FAdV-4 strain HLJFAd15 (GenBank No. KU991797) was isolated in our previous study [19 (link)]. The artificial non-pathogenic strain rHN20 is a chimeric virus generated by replacing its hexon gene with that of ON1 (GenBank No. GU188428) using HLJFAd15 as the backbone [20 (link)]. The recombinant FAdV-4 rWT-EGFP strain expressing EGFP was derived by inserting an EGFP expression cassette at the 1966-bp site of the natural deletion in the HLJFAd15 genome. All viruses were amplified in LMH cells and stored at –80 °C. The HLJFAd15 and rHN20 viral titers were titrated with plaque-forming units (PFU) in monolayer LMH cells. The median tissue culture infective dose (TCID50) was used to calculate the viral titer of rWT-EGFP according to the expression of EGFP. The titers of HLJFAd15, rHN20 and rWT-EGFP were 1.36 × 107 PFU/mL, 3.14 × 107 PFU/mL, and 107.67 TCID50/mL, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!